These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 4013413)

  • 21. Antibody response to influenza vaccine in adults vaccinated with identical vaccine strains in consecutive years.
    Nabeshima S; Kashiwagi K; Murata M; Kanamoto Y; Furusyo N; Hayashi J
    J Med Virol; 2007 Mar; 79(3):320-5. PubMed ID: 17245715
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Characteristics of influenza immunity and prospects of achieving virus-specific prevention of influenza].
    Shvartsman IaS; Tsybul'skaia NV; Ispolatova AV
    Usp Sovrem Biol; 1982; 94(3):446-60. PubMed ID: 6186100
    [No Abstract]   [Full Text] [Related]  

  • 23. Augmentation of the immune response to influenza vaccine by acetylsalicylic acid: a clinical trial in a geriatric population.
    Hsia J; Tang T; Parrott M; Rogalla K
    Methods Find Exp Clin Pharmacol; 1994 Nov; 16(9):677-83. PubMed ID: 7746030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Parenteral vaccination against influenza does not induce a local antigen-specific immune response in the nasal mucosa.
    Brokstad KA; Eriksson JC; Cox RJ; Tynning T; Olofsson J; Jonsson R; Davidsson A
    J Infect Dis; 2002 Apr; 185(7):878-84. PubMed ID: 11920311
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influenza vaccine for children.
    Neuzil KM
    Clin Infect Dis; 2004 Mar; 38(5):689-91. PubMed ID: 14986253
    [No Abstract]   [Full Text] [Related]  

  • 26. [Inactivated influenza vaccine (H1N1, H3N2, H3N1) - antibody response and protective effect in the influenza epidemic H1N1 in 1979 (author's transl)].
    Bruj J; Skocil V; Farník J; Hronovský F; Síp J
    Cesk Epidemiol Mikrobiol Imunol; 1981 Sep; 30(5):287-93. PubMed ID: 6456837
    [No Abstract]   [Full Text] [Related]  

  • 27. [Which influenza vaccination is the best - with whole virus, split vaccine or subunit vaccines?].
    Klenk HD; Stickl H
    Med Welt; 1981 Jun; 32(25):1008-9. PubMed ID: 7278577
    [No Abstract]   [Full Text] [Related]  

  • 28. [Immunogenicity and safety of domestic slit influenza vaccine].
    Zhu XJ; Zhang ZL; Li H; Su X; Guo XH; Chen W; Kou M; Duan WP
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jul; 25(7):644. PubMed ID: 15308057
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparison of the safety, vaccine virus shedding, and immunogenicity of influenza virus vaccine, trivalent, types A and B, live cold-adapted, administered to human immunodeficiency virus (HIV)-infected and non-HIV-infected adults.
    King JC; Treanor J; Fast PE; Wolff M; Yan L; Iacuzio D; Readmond B; O'Brien D; Mallon K; Highsmith WE; Lambert JS; Belshe RB
    J Infect Dis; 2000 Feb; 181(2):725-8. PubMed ID: 10669363
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Evaluation of seroconversion after vaccination against influenza during the epidemic season 1991-1992 in Poland].
    Brydak L; Rudnicka H
    Przegl Epidemiol; 1993; 47(3):275-83. PubMed ID: 8234846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Antibody formation and preservation against the envelope antigens of influenza virus subtype A(H3N2) after infection and vaccination].
    Stumpa A; Tůmová B
    Tr Inst Im Pastera; 1982; 59():23-8. PubMed ID: 6764986
    [No Abstract]   [Full Text] [Related]  

  • 32. National Advisory Committee on Immunization (NACI). Statement on influenza vaccination for the 1994-95 season.
    Can Commun Dis Rep; 1994 Jun; 20(11):85-92. PubMed ID: 7522728
    [No Abstract]   [Full Text] [Related]  

  • 33. Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential.
    Desheva JA; Lu XH; Rekstin AR; Rudenko LG; Swayne DE; Cox NJ; Katz JM; Klimov AI
    Vaccine; 2006 Nov; 24(47-48):6859-66. PubMed ID: 17050041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancement of antibody responses to influenza B virus haemagglutinin by use of a new adjuvant formulation.
    Byars NE; Allison AC; Harmon MW; Kendal AP
    Vaccine; 1990 Feb; 8(1):49-56. PubMed ID: 2316284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Parenteral influenza vaccination induces a rapid systemic and local immune response.
    Brokstad KA; Cox RJ; Olofsson J; Jonsson R; Haaheim LR
    J Infect Dis; 1995 Jan; 171(1):198-203. PubMed ID: 7798664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influenza vaccination in dialysis and transplant patients.
    Versluis DJ; Beyer WE; Masurel N; Weimar W
    Antiviral Res; 1985; Suppl 1():289-92. PubMed ID: 3909959
    [No Abstract]   [Full Text] [Related]  

  • 37. Enhanced lymphoproliferation to influenza A virus following vaccination of older, chronically ill adults with live-attenuated viruses.
    Gorse GJ; Belshe RB
    Scand J Infect Dis; 1991; 23(1):7-17. PubMed ID: 2028230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and immunogenicity of a 45-microgram supplemental dose of inactivated split-virus influenza B vaccine in the elderly.
    Arden NH; Patriarca PA; Lui KJ; Harmon MW; Brandon F; Kendal AP
    J Infect Dis; 1986 Apr; 153(4):805-6. PubMed ID: 3950454
    [No Abstract]   [Full Text] [Related]  

  • 39. [Local and general immune responses in rabbits after intratracheal administration of influenza virus (author's transl)].
    Riottot MM; Thibon M; Pillot J
    Ann Microbiol (Paris); 1977; 128A(4):459-75. PubMed ID: 911110
    [No Abstract]   [Full Text] [Related]  

  • 40. [Dynamics of the specific antibodies in persons with unaltered palatine tonsils, in chronic tonsillitis and in persons with the tonsils removed immunized with a live influenza vaccine].
    Gorbachevskiĭ VN
    Zh Ushn Nos Gorl Bolezn; 1978; (1):67-74. PubMed ID: 636625
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.